Jacobs Levy Equity Management’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-123,688
| Closed | -$1.38M | – | 1090 |
|
|
2020
Q3 | $1.38M | Sell |
123,688
-62,662
| -34% | -$699K | 0.01% | 592 |
|
|
2020
Q2 | $2.52M | Buy |
186,350
+114,155
| +158% | +$1.54M | 0.03% | 478 |
|
|
2020
Q1 | $583K | Buy |
72,195
+26,342
| +57% | +$213K | 0.01% | 729 |
|
|
2019
Q4 | $441K | Buy |
45,853
+35,788
| +356% | +$344K | ﹤0.01% | 800 |
|
|
2019
Q3 | $107K | Buy |
+10,065
| New | +$107K | ﹤0.01% | 887 |
|
|
2019
Q2 | – | Sell |
-38,222
| Closed | -$490K | – | 1019 |
|
|
2019
Q1 | $490K | Buy |
38,222
+22,782
| +148% | +$292K | 0.01% | 777 |
|
|
2018
Q4 | $95K | Sell |
15,440
-1,083
| -7% | -$6.66K | ﹤0.01% | 943 |
|
|
2018
Q3 | $174K | Sell |
16,523
-17,155
| -51% | -$181K | ﹤0.01% | 939 |
|
|
2018
Q2 | $494K | Buy |
+33,678
| New | +$494K | 0.01% | 801 |
|